Bayer flags US$750m higher Roundup settlement bill
[FRANKFURT] Drugs and farming pesticides maker Bayer said the costs of its settlement over claims its Roundup weedkiller causes cancer, initially put at US$11 billion, would be US$750 million higher.
Bayer struck an agreement in principle with US plaintiff's lawyers in June but a judge later took issue with a side arrangement on future cases that may yet be lodged, known as a class plan.
"Bayer took an additional provision in the third quarter to cover the increased cost of a revised class plan, as it is far enough along in the negotiations to know that the new plan will come in at approximately US$2 billion, an increase over the original cost of US$1.25 billion," Bayer said in a statement on Monday.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Nanjing Xinjiekou Department Store announces May 23 EGM; Cordlife seeking legal advice
Olam tops Louis Dreyfus’ offer for Australia’s Namoi Cotton as takeover battle heats up
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
‘Limits’ to MOH intervention for Cordlife customer refunds, compensation: Janil
UG Healthcare fully acquires German associate company for 16.9 million euros
AstraZeneca says it will withdraw Covid-19 vaccine globally as demand dips